Breast cancer (invasive) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-COWDEN-SUSPICION-PREVENTION-GENETIC-COUNSELING |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-BREAST |
| Sources | SRC-NCCN-BREAST-2025 SRC-NCCN-GENETIC-FAMILIAL-BREAST-OVARIAN-2025 |
Notes
STUB — v0.2-B hereditary pilot (Cowden, additional). NCCN Genetic/Familial High-Risk Breast Ovarian Pancreatic 2025 includes the Cowden surveillance section; dedicated PTEN-syndrome sources (Tan et al. Clin Cancer Res 2012; Eng et al. PHTS clinical guidelines) are v0.2-B authoring backlog. Two-Co-Lead signoff queued.
Used By
Red flag
RF-COWDEN-FAMILY-HISTORY-SUSPICION- Family pedigree suggestive of Cowden syndrome / PTEN hamartoma tumor syndrome (PHTS): any...